Timothy J. Wiegand MD, FACMT, FAACT, DFASAM

Dr. Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM, serves as Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester School of Medicine and the University of Rochester Medical Center. He is currently the Director of Addiction Medicine in the Department of Emergency Medicine at URMC, transitioning from directing the integrated Addiction/Toxicology Consult Service, which he founded in 2011. This program has been a model, and Dr. Wiegand has mentored other professionals on Addiction/Toxicology program development, patient care, and billing and reimbursement. These professionals and Addiction/Toxicology specialists now run similar programs around the country.

Dr. Wiegand started treating addiction during his Internal Medicine Residency at Hennepin County Medical Center in Minneapolis, Minnesota (2001-2004), where he was mentored in withdrawal management and later in methadone treatment through a formal program for Internal Medicine trainees. After residency, Dr. Wiegand completed a dual Medical Toxicology and Clinical Pharmacology Fellowship at the University of California, San Francisco, and he has since worked to bridge the fields of addiction medicine and medical toxicology, seeing tremendous opportunities professionally, in expanding the addiction workforce, and for public health in the overlap and collaboration between the two medical specialties. In addition to emergency department, hospital, and clinic work treating drug exposures, intoxication, withdrawal, and assisting with pain and perioperative management for patients treated with buprenorphine or methadone, Dr. Wiegand is involved with medical education and research in toxicology and addiction.

In addition to his position at URMC, Dr. Wiegand serves as the Medical Director for Huther Doyle, an outpatient addiction treatment program that is certified under New York’s Office of Addiction Services and Supports (OASAS). Dr. Wiegand is the initial Program Director for the URMC Medical Toxicology Fellowship, which became ACGME-certified in 2023. He is a past Program Director for the URMC Emergency Medicine & Toxicology-based Addiction Medicine Fellowship Program, and his fellows have all become Board-certified in Addiction Medicine and gone on to practice in this area, making important contributions to patient care and in their professional work. He is also a core faculty member for the Emergency Medicine residency at Strong Memorial Hospital, and he has run a Toxicology and Addiction rotation, which he developed in 2010. He lectures locally, regionally, nationally, and internationally on topics in addiction medicine and medical toxicology.

Dr. Wiegand has served two terms on the ASAM Board’s Executive Council, and he has served on the ASAM Board overall for nearly six years. He currently serves ASAM as Treasurer, and he is also a past ASAM Vice President. Before serving as Vice President, Dr. Wiegand was an At-Large Board Director for ASAM. He has also served on the nominations committee and participated in numerous other groups, including expert panels, in the development of educational content, and in the creation of Position Statements and Guidelines (e.g., Drug Testing in Clinical Addiction Medicine and the Stimulant Use Disorder Guidance documents). He is also a Co-Chair of a new Forensic Addiction Medicine Special Interest Group, which is a new opportunity for ASAM members to get involved with.